Global Veterinary Anti-Infectives Market to Reach USD 13.27 Billion by 2032, Driven by Rising Animal Disease Incidence and Advanced Therapeutics

Rising Prevalence of Animal Infectious Diseases is Driving Veterinary Anti-Infectives Market Expansion

The veterinary anti-infectives market size was valued at USD 8.32 billion in 2024 and is expected to reach USD 13.27 billion by 2032, growing at a CAGR of 6.10% over the forecast period of 2025-2032.

The increasing incidence of infectious diseases in livestock and companion animals remains a key driver of the veterinary anti-infectives market. Diseases such as bovine respiratory disease, swine dysentery, mastitis, and avian influenza pose significant threats to intensive farming systems, affecting cattle, poultry, and swine. Similarly, pets experience bacterial skin infections, urinary tract infections, and respiratory diseases, especially in aging or immunocompromised animals. Rapid identification and treatment of these infections have created a high demand for antibiotics, antifungals, antivirals, and antiparasitics, further propelling market growth.

According to the World Organisation for Animal Health (WOAH), outbreaks in mammals have more than doubled over the past 20 years, with 1,022 outbreaks reported in 55 countries—an increase of 123% compared to 2023. From January 2024 to April 2025 alone, over 6,800 outbreaks of African swine fever, 3,500 of HPAI, and 3,600 cases of bluetongue disease were recorded globally. These alarming statistics underscore the urgent need for effective animal disease control, driving the adoption of veterinary anti-infectives.

Stay Ahead with Market Trends: Access Your Sample Report Now: https://www.snsinsider.com/sample-request/7803

Advancements in Veterinary Diagnostics and Drug Discovery Enhance Market Growth

The development of advanced veterinary diagnostics has improved the speed and accuracy of disease detection, enabling more precise and timely treatment interventions. PCR, ELISA, and rapid point-of-care tests have become essential in veterinary practice, distinguishing bacterial, viral, and parasitic infections and allowing for targeted therapies.

Technological advances in drug formulation, including long-acting injectables, combination therapies, and species-specific drugs, have also enhanced treatment compliance and therapeutic outcomes. These innovations are particularly critical in managing infectious diseases, promoting the safe and efficient use of anti-infectives, and contributing to the market's upward trajectory.

Regulatory Challenges Pose a Restraint on Market Expansion

Stringent regulatory requirements imposed by authorities such as the U.S. FDA and the European Medicines Agency govern the approval, manufacturing, and marketing of veterinary drugs. Extensive clinical trials, rigorous documentation, and adherence to good manufacturing practices often delay product launches and increase operational costs.

Moreover, antimicrobial stewardship programs and restricted use policies, particularly in North America and Europe, limit the development and use of certain anti-infectives, especially antibiotics. While these regulations are essential to combat antimicrobial resistance (AMR), they also present significant challenges for manufacturers, particularly smaller enterprises, seeking market entry.

Market Segmentation Analysis: Animal Type, Product, Route of Administration, Type, and Distribution Channel

In 2024, livestock animals accounted for 68.5% of the veterinary anti-infectives market share, driven by the high consumption of anti-infectives for food-producing animals. Increased meat and dairy demand, coupled with biosecurity regulations, further strengthens this segment. The companion animal segment, fueled by rising pet ownership, greater spending on pet health, and early preventive care, is expected to witness the fastest growth in the forecast period.

Antimicrobials dominate the market with 52.14% share in 2024 due to their wide use in treating bacterial infections and controlling outbreaks in industrial-scale livestock operations. Antivirals are anticipated to be the fastest-growing segment as viral diseases such as Feline leukemia virus, canine parvovirus, and swine influenza gain prominence, coupled with increasing investment in targeted antiviral therapies and vaccines.

Oral administration dominates the market at 72.26% share, favored for its convenience, cost-effectiveness, and suitability for mass treatment. Other routes, including topical and intramammary applications, are growing rapidly due to advances in localized delivery and long-acting formulations.

Over-the-counter (OTC) products held 73.10% market share in 2024, offering accessibility, affordability, and convenience for minor infections and preventive care. Prescription anti-infectives are projected to grow fastest due to regulatory emphasis on AMR and increased demand for precise treatments in complex infections.

Retail pharmacies remain the primary distribution channel, capturing 76% of the market in 2024, supported by their extensive reach in urban and rural areas. E-commerce platforms are emerging as the fastest-growing distribution channel, driven by digitalization, tele-veterinary services, and the convenience of home delivery for both companion and livestock animals.

Key Players

Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Norbrook Laboratories

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights: https://www.snsinsider.com/reports/veterinary-anti-infectives-market-7803

Regional Insights: North America, Asia Pacific, Europe, and Emerging Markets

North America leads the global veterinary anti-infectives market, accounting for 36.12% in 2024. Strong veterinary care infrastructure, robust regulatory frameworks, and the presence of major industry players, such as Zoetis, Merck Animal Health, and Elanco Animal Health, drive market dominance. Recent strategic acquisitions and investments in R&D reinforce this leadership.

Asia Pacific is projected to be the fastest-growing region, with a CAGR of 6.67%, supported by an expanding livestock population, urbanization, increasing meat and dairy consumption, and government-led modernization initiatives in animal farming. China and India are emerging as key markets due to rising awareness of zoonotic diseases and increasing investment in veterinary care.

Europe is witnessing substantial growth driven by regulatory initiatives, antimicrobial stewardship, and growing awareness about animal welfare and companion animal health. Latin America and the Middle East & Africa (MEA) show moderate growth, supported by expanding livestock farming, increasing zoonotic disease awareness, and gradual improvement of veterinary healthcare infrastructure.

Future Outlook: Innovations, Strategic Investments, and Sustainable Growth

The veterinary anti-infectives market is expected to maintain a strong growth trajectory through continued advancements in diagnostics, drug discovery, and innovative delivery systems. Increased focus on antimicrobial stewardship, targeted therapies, and precision veterinary medicine will create opportunities for both new entrants and established players. Strategic acquisitions, such as Merck Animal Health’s USD 1.3 billion purchase of Elanco’s aquaculture business, and Zoetis’ marketing rights acquisition of Loncor 300, highlight ongoing consolidation and expansion in the market. Emerging digital solutions, tele-veterinary services, and e-commerce channels will further reshape distribution models, enhancing accessibility and convenience.

Conclusion: Veterinary Anti-Infectives Market Poised for Robust Growth

The global veterinary anti-infectives market is set for robust expansion, driven by rising infectious disease prevalence, technological advancements in diagnostics and therapeutics, and growing awareness of companion and livestock animal health. While regulatory constraints pose challenges, the market continues to benefit from increased pet ownership, urbanization, and the modernization of livestock practices in emerging regions. Strategic collaborations, innovations in drug delivery, and evolving e-commerce channels are expected to create sustained opportunities through 2032.

Other Trending Reports

Urine Testing Cups Market

Neurocognitive Assessment and Rehabilitation Market

Toxicity Testing Outsourcing Market

Coronary Stent Market